Founded in 2013, Aptissen is a Swiss company leading-edge musculoskeletal expert that provides life-changing orthobiologic solutions for articulation disorders.
The Aptissen founders developed a unique hyaluronic acid injectable: Synolis VA to reduce the pain and discomfort caused by osteoarthrosis.
In 2019, Aptissen added to its portfolio Cartylis, a daily drinkable food supplement that promotes collagen synthesis to reboost the joints.
The company’s products are distributed through a worldwide distributors network among more than 50 countries, including Switzerland, France, Italy, Poland, Canada, Mexico, Brazil, UAE, Singapore Malaysia etc.…
Aptissen launched Synolis VA, an intra-articular injection product for osteoarthritis, the first Visco-Antalgic on the market, with a unique combination of Hyaluronic Acid and high concentration of Sorbitol.
Synolis VA’s viscoelastic properties (patented formulation) are similar to the young and healthy synovial fluid, resulting in rapid mobility recovery, fast and long-lasting pain relief associated with excellent safety.